Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patterns, along with glycemic levels and comorbidities, and possible benefits of novel ADDs in delaying the need for insulin initiation in patients diagnosed with type 2 diabetes. Patients with type 2 diabetes aged...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2018-01, Vol.41 (1), p.69-78
Hauptverfasser:	Montvida, Olga, Shaw, Jonathan, Atherton, John J, Stringer, Frances, Paul, Sanjoy K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Amplification Antidiabetics Blood Glucose - analysis Comorbidity Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Drug therapy Electronic health records Electronic medical records Female Follow-Up Studies GLP-1 receptor agonists Glucagon Glucagon-like peptide 1 Glucagon-Like Peptide-1 Receptor - agonists Glucagon-Like Peptide-1 Receptor - metabolism Glycemic index Humans Hypoglycemic Agents - therapeutic use Incretins - therapeutic use Insulin Insulin - therapeutic use Longitudinal Studies Male Medical diagnosis Metformin Metformin - therapeutic use Middle Aged Patients Peptidase Research design Sulfonylurea Sulfonylurea Compounds - therapeutic use Therapy Time Factors Trends Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!